Jasper van der Lugt

7PUBLICATIONS
40CO-AUTHORS
Molecular targetsInfant and child healthCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 16, 2025
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Mar 13, 2025
Unusual Partners: γδ-TCR-Based T Cell Therapy in Combination with Oncolytic Virus Treatment for Diffuse Midline Gliomas.

Konstantinos Vazaios, Patricia Hernández López, Tineke Aarts-Riemens

|Aug 14, 2024
Bone health in childhood low-grade glioma: an understudied problem.

I M A A van Roessel, J E Gorter, B Bakker

|May 11, 2024
OV Modulators of the Paediatric Brain TIME: Current Status, Combination Strategies, Limitations and Future Directions.

Konstantinos Vazaios, Ronja E van Berkum, Friso G Calkoen

|Mar 12, 2024
Author Correction: The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

|Nov 18, 2023
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.

Lindsay B Kilburn, Dong-Anh Khuong-Quang, Jordan R Hansford

Pageof 2

Frequent Collaborators

3 joint publications

Sarah E S Leary

3 joint publications

Darren Hargrave

3 joint publications

David S Ziegler

3 joint publications

Pablo Hernáiz Driever